Related Experiment Video
Updated: Jul 21, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy
S Lehto1, T Rönnemaa, K Pyörälä
1Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
Insights
Poor metabolic control significantly predicts coronary heart disease (CHD) events in type 1 diabetes patients without kidney disease. High HbA1c and long diabetes duration are key risk factors for CHD death.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Patients with type 1 diabetes mellitus (T1DM) face elevated risks for coronary heart disease (CHD), particularly those with nephropathy.
- Predictive value of cardiovascular risk factors and hyperglycemia for CHD events in T1DM patients without nephropathy remains incompletely understood.
Purpose of the Study:
- To prospectively investigate cardiovascular risk factors for CHD events in T1DM patients without clinical nephropathy.
- To identify specific predictors of CHD mortality and morbidity in this patient cohort.
Main Methods:
- A prospective study involving 177 T1DM patients (aged 45-64 at baseline, diagnosed ≥30 years prior) without clinical nephropathy.
- Baseline assessment of cardiovascular risk factors, followed by up to 7 years of monitoring for CHD events (death from CHD, nonfatal myocardial infarction).
- Multivariate Cox regression analysis to identify independent predictors of CHD events.
Main Results:
- Over 7 years, 20 patients died from CHD and 28 experienced a serious CHD event.
- Independent predictors of CHD death included prior myocardial infarction (HR 8.0), high glycohemoglobin A1c (HbA1c) >10.4% (HR 5.4), and diabetes duration >16 years (HR 4.2).
- These factors also predicted the overall incidence of CHD events.
Conclusions:
- Poor metabolic control, indicated by high HbA1c and prolonged diabetes duration, is a strong independent predictor of CHD events in T1DM patients without nephropathy.
- These findings highlight the importance of glycemic control in preventing cardiovascular complications in this population.
Abstract:
Patients with type 1 diabetes mellitus, especially those with nephropathy, are at increased risk for coronary heart disease (CHD). However, information on the predictive value of cardiovascular risk factors and the degree of hyperglycemia with respect to CHD events in patients with type 1 diabetes without nephropathy is still incomplete. Therefore, we performed a prospective study on risk factors for CHD in patients with type 1 diabetes free of clinical nephropathy. At baseline examination, cardiovascular risk factor levels of CHD were determined in 177 patients with type 1 diabetes (87 men and 90 women), age 45 to 64 years at baseline and >/=30 years at the time of diagnosis of diabetes. These patients were followed up to 7 years with respect to CHD events. Altogether, 20 patients with type 1 diabetes (13 men [7.3%] and 7 women [3.9%]) died of CHD and 28 patients with type 1 diabetes (17 men [9.6%] and 11 women [6.2%]) had a serious CHD event (death from CHD or nonfatal myocardial infarction). In multivariate Cox regression analysis, a previous history of myocardial infarction (hazard ratio [HR] and its 95% confidence interval, 8.0 [3.1 to 21.0], P<0.001), high glycohemoglobin A1 (>10.4%, the highest tertile, HR 5.4 [1.4 to 20.4], P=0.013), and the duration of diabetes (>16 years, the highest tertile, HR 4.2 [1.3 to 12.9], P=0.013) were the only variables associated with CHD death even after adjustment for other cardiovascular risk factors. These variables also predicted the incidence of all CHD events. Our results indicate that poor metabolic control is a strong predictor of CHD events in patients with late-onset type 1 diabetes without nephropathy, independently of other cardiovascular risk factors.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Nephropathy

